Specialisation
Retina and Vitreous - Genetics
Full title
Phase IV clinical trial to evaluate genetic variants of the VEGF pathway as biomarkers of efficacy of aflibercept treatment in patients with neovascular age-related macular degeneration (AMD). More information here.
Promoter
Fundación IMO.
Start date
December 2014
End date
March 2017
Researchers
Main: Dr. Rafael Navarro.
